Blog · fresh, dated, cited
GLP-1, current — what changed and what the data says in 2026.
Answer-first explainers for the questions people are actually searching this year, each one grounded in FDA prescribing information and peer-reviewed trials. For the evergreen fundamentals, start with our GLP-1 guides.
Microdosing GLP-1 in 2026
Microdosing GLP-1 medications is everywhere — but what does the evidence say? An honest look at what it means, why people do it, and what's known about safety.
Missed Your Wegovy Dose? (2026)
Missed a Wegovy shot? The '2-day' and '4-day' rules get confused online. Here's the FDA-label answer for Wegovy: when to take it late, and when to skip.
Oral GLP-1 Tracking in 2026
How the daily oral GLP-1 tablet schedule works, why the empty-stomach rule is non-negotiable, and what's worth tracking when your GLP-1 is a pill, not a shot.
Protein target on GLP-1 (g/kg), 2026 guide
How much protein should you aim for on a GLP-1? A source-backed look at targets in grams per kilogram, and how to hit the number when your appetite is low.
Semaglutide mg to Units (2026)
Converting a semaglutide dose from mg to insulin-syringe units? The answer depends on your vial's concentration — here's the arithmetic, and why charts are risky.
Zepbound Plateau at Week 12? (2026)
Stalled on Zepbound around week 12? Before assuming tirzepatide stopped working, check dose timing, steady state and titration stage — from the FDA label.
Educational content — not medical advice. Every post is compiled from FDA prescribing information and cited clinical trials; see our editorial policy for how these are written and refreshed.
Reading is good. A record is better.
Track the journey these posts describe — free.